<DOC>
	<DOCNO>NCT00290264</DOCNO>
	<brief_summary>The primary objective compare efficacy Symbicort Single inhaler Therapy treatment accord conventional best practice adolescent adult patient persistent asthma .</brief_summary>
	<brief_title>SALTO - Symbicort Single Inhaler Therapy Use Adolescent Adults Adults With Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Minimum 3 month document history asthma , diagnose accord American Thoracic Society ( ATS ) definition . Prescribed inhale GCS dose ≥320 µg/day within approve label relevant drug last 3 month prior Visit 1 . Use bblocking agent , include eyedrop . Use oral GCS maintenance treatment . Known suspected hypersensitivity study therapy excipients . A history smoking ≥ 10 pack year ( 1 pack year = 1 pack ( 20 cigarette ) per day one year equivalent ) .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>